#151130

Anti-CD1c [M241] mAb

Cat. #151130

Anti-CD1c [M241] mAb

Cat. #: 151130

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 1-2 weeks

Target: CD1c (Human Thymus Leukaemia antigen)

Class: Monoclonal

Application: IHC ; IP ; RIA

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Walter Bodmer

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD1c [M241] mAb
  • Alternate name: CD1c Molecule; CD1C Antigen; C Polypeptide; CD1c Antigen; Differentiation Antigen CD1-Alpha-3; Cortical Thymocyte Antigen; CD1C; BDCA1; CD1A; CD1; R7
  • Research fields: Cancer;Cell biology;Immunology
  • Clone: M241
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 45 kDa
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC ; IP ; RIA
  • Description: M241 is useful for identification and elimination of some leukaemias.
  • Immunogen: MOLT 4 cell line
  • Isotype: IgG1
  • Myeloma used: P3/NS1/1-Ag4.1

Target Details

  • Target: CD1c (Human Thymus Leukaemia antigen)
  • Molecular weight: 45 kDa
  • Target background: Cluster of Differentiation 1c (CD1c) is one of five human CD1 isoforms, a family of b2-microglobulin-associated transmembrane proteins that bind and present lipid antigens to T cells.

Applications

  • Application: IHC ; IP ; RIA

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • MiR-381-3p Regulates the Antigen-Presenting Capability of Dendritic Cells and Represses Antituberculosis Cellular Immune Responses by Targeting CD1c.
  • Wen et al. 2016. J Immunol. :. PMID: 27296666.
  • Small et al. 1989. Hum Immunol. 25(3):181-93. PMID: 2670851.
  • Characterization of B cells in severe combined immunodeficiency disease.
  • Merle-Beral et al. 1988. Eur J Haematol. 41(3):197-203. PMID: 3263283.
  • Phenotypic heterogeneity of B- and T-cell differentiation antigens in B-CLL.
  • Matsumoto et al. 1986. J Immunol. 137(9):2907-12. PMID: 2428878.
  • Fn analysis of activated C1s, a subcomponent of the first component of human complement, by monoclonal antibodies.
  • Knowles et al. 1982. Eur J Immunol. 12(8):676-81. PMID: 6754387.
  • A monoclonal antibody recognizing a human thymus leukemia-like antigen associated with beta 2-microglobulin.